If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
222.50    -2.50 (-1.11%)
Bid:
220.00
Ask:
225.00
Spread: 5.00 (2.273%)
Market Cap: £107.81m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Directorate Changes and Trading Update

21 May 2021 07:00

RNS Number : 4109Z
Quartix Holdings PLC
21 May 2021
Β 

Quartix Holdings plc

("Quartix", "the Group" or "the Company")

Directorate Changes and Trading Update

Quartix Holdings PLC (AIM: QTX), a leading supplier of vehicle tracking systems, is pleased to announce that, as noted in its trading update of 11 January 2021, Emily Rees has been promoted to Chief Financial Officer and joins the board of Quartix Holdings plc as an Executive Director of the Company with immediate effect. She replaces Daniel Mendis who has stepped down from the Company's Board and who will now devote his time entirely to commercial and operational matters.

Ms. Rees has spent the past three years in senior financial positions within KRM (Great Britain) Limited (trading as Ecco Shoes), most recently as Regional Head of Finance and HR for Western Europe. Prior to this she worked for Pizza Express (Restaurants) Limited and Tesco Stores Limited. Ms. Rees is a member of the Chartered Institute of Management Accountants and holds a BSc (Hons) in Government and Economics from the London School of Economics and Political Science. Ms. Rees joined the Company as Finance Director in April and will be based at the Newtown Office as soon as it reopens.

Mr Mendis, who was previously Chief Operating and Financial Officer, has taken up the new role of Group Commercial and Operations Director in which he will focus specifically on development of the fleet business, including responsibility for all sales channels worldwide.

Trading Update

The Board is pleased to report that the Company has made good progress in 2021 and that trading for the four-month period to 30 April 2021 was consistent with meeting market expectations for the year*. A more detailed trading update will be provided in early July.

Β 

Andy Walters, Chief Executive Officer of Quartix commented:

Β 

"We are delighted to welcome Emily to the Board at Quartix. The financial and commercial experience she has gained in her previous roles will be of great use in her new role. She has quickly developed a good understanding of our business and we are pleased to confirm her appointment to the Board.

Β 

Daniel Mendis has made a very significant contribution to the Company since joining us in January 2018 and we are pleased to be able to be able to offer him this new role, which is key to the development of our business and his career path.

Β 

I look forward to continuing to work with Emily and Dan as we continue to grow our fleet business."

Β 

* The Board believes that consensus market expectations for 2021 prior to this announcement, were as follows: Revenue: Β£25.6m; Adjusted EBITDA Β£5.1m; Underlying Free Cash Flow (before expenditure on 3G swap out in the US - see 2020 Annual Report): Β£4.0m.

Β 

For further information, please contact:

QuartixΒ (www.quartix.net)

Andrew Walters, Chief Executive

Β 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode / Kate Bannatyne (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

Β 

Regulatory disclosures

Β 

In accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies, Emily Catherine Rees (formerly Emily Catherine Roberts), aged 31, is, or has been within the last five years, a director or partner in the following companies and partnerships:

Β 

Current directorships and partnerships

Past directorships and partnerships held within the last five years

Manbey Mews Ltd

N/A

Β 

Β 

Emily does not have an interest in any Quartix shares. There is no other information required to be disclosed under Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPPUUCAUPGUCG
Date   Source Headline
8th Jul 20267:00 amRNSTrading Statement
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.